Calcified Tissue International

, Volume 37, Issue 3, pp 318–323 | Cite as

Skeletal adenylate cyclase: Effect of Mg2+, Ca2+, and PTH

  • Robert K. Rude
Laboratory Investigations


Plasma membranes were prepared from mineralized guinea pig bone in order to study Mg2+ and Ca2+ modulation of skeletal adenylate cyclase. Plasma membrane preparation was accomplished by crushing the bone in liquid N2 and subsequent multiple washings in buffer containing EGTA to remove all Ca2+ prior to adenylate cyclase assay. Skeletal adenylate cyclase was found to be dependent on GTP and Mg2+ and responsive to bovine 1-34 PTH. Ca2+ caused a competitive inhibition of Mg2+-activated skeletal adenylate cyclase. The apparent KaMg was 1.9±0.3 in the presence of 0.2 μM Ca2+ but increased to a mean of 7.2±1.3 in the presence of 5.0 μM Ca2+. Analysis of the Ca2+ inhibition curves at concentrations from .05 μM-1.0 mM were consistent with the presence of two Ca2+ inhibition sites, one with an apparent Ki of 1–2 μM and the other with an apparent Ki of approximately 500 μM. Lowering the Mg2+ concentration increased the contribution of the high affinity Ca2+ binding site to the overall Ca2+ inhibition, and raising the Mg2+ concentration had the opposite effect. While bPTH 1-34 enhanced adenylate cyclase activity, it did not increase the affinity of Mg2+ for skeletal adenylate cyclase nor did it alter the KiCa or the pattern of Ca2+ inhibition. These data may explain the skeletal resistance to PTH during Mg deficiency. A fall in the intracellular Mg would render the adenylate cyclase more susceptible to inhibition by the prevailing intracellular Ca2+ concentration. Since PTH does not appear to modulate either Mg2+ activation or Ca2+ inhibition of skeletal adenylate cyclase, cAMP-mediated PTH induction of bone resorption would be impaired, and hypocalcemia would occur.

Key words

Skeleton Magnesium Calcium Parathyroid hormone Adenylate cyclase 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Estep H, Shaw WA, Watlington C, Hobe R, Holland W, Tucker STG (1969) Hypocalcemia due to hypomagnesemia and reversible parathyroid hormone unresponsiveness. J Clin Endocrinol 29:842–848CrossRefGoogle Scholar
  2. 2.
    Rude RK, Oldham SB, Singer FR (1976) Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol (Oxf) 5:209–224Google Scholar
  3. 3.
    Shils ME (1976) Magnesium deficiency and calcium and parathyroid hormone inter-relations. In: Prasad, AS (ed) Trace elements in human health and disease. Academic Press, New York, p 23Google Scholar
  4. 4.
    Cech SY, Broaddus WC, Maguire ME (1980) Adenylate cyclase: the role of magnesium and other divalent cations. Mol Cell Biochem 33:67–92PubMedCrossRefGoogle Scholar
  5. 5.
    Freitag JJ, Martin KJ, Conrades MB, Bellorin-Font E, Teitelbaum S, Klahr S, Slatopolsky E (1979) Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. J Clin Invest 64:1238–1244PubMedCrossRefGoogle Scholar
  6. 6.
    Rude RK (1983) Renal cortical adenylate cyclase: characterization of magnesium activation. Endocrinology 113:1348–1355PubMedGoogle Scholar
  7. 7.
    Oldham SB, Rude RK, Molloy CT, Lipson LG (1984) The effects of magnesium on calcium inhibition of parathyroid adenylate cyclase. Endocrinology 115:1883–1890PubMedGoogle Scholar
  8. 8.
    Smith DM, Johnston CC Jr. (1974) Hormonal responsiveness of adenylate cyclase activity from separated bone cells. Endocrinology 95:130–139PubMedGoogle Scholar
  9. 9.
    Bartfai, T (1979) Preparation of metal-chelate complexes and the design of steady-state kinetic experiments involving metal nucleotide complexes. Adv Cyclic Nucleotide Res 10:219–242PubMedGoogle Scholar
  10. 10.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  11. 11.
    Oldham SB, Molloy CT, Lipson LG (1984) Calcium inhibition of parathyroid adenylate cyclase. Endocrinology 114:207–214PubMedGoogle Scholar
  12. 12.
    Shoback D, Thatcher J, Leombruno R, Brown E (1983) Effects of extracellular Ca++ and Mg++ on cytosolic Ca++ and PTH release in dispersed bovine parathyroid cells. Endocrinology 113:424–426PubMedCrossRefGoogle Scholar
  13. 13.
    Garfinkel L, Garfinkel D (1984) Calculation, of free-Mg2+ concentrations in adenosine 5′-triphosphate containing solutions in vitro and in vitro. Biochemistry 23:3547–3552PubMedCrossRefGoogle Scholar
  14. 14.
    Bird SJ, Maguire ME (1978) The agonist-specific effects of magnesium ion on binding by B adenergic receptors in S49 lymphoma cells. J Biol Chem 253:8826–8834PubMedGoogle Scholar
  15. 15.
    Narayanan N, Sulakhe PV (1977) 5′-Guanylylimidodi phosphate-activated adenylate cyclase of cardiac sarcolemma displays higher affinity for magnesium ions. Mol Pharmacol 13:1033–1047PubMedGoogle Scholar
  16. 16.
    Narayanan N, Wei J, Sulakhe PV (1979) Differences in the cation sensitivity of adenylate cyclase from heart and skeletal muscle: modification by guanyl nucleotides and isoproterenol. Arch Biochem Biophys 197:18–29PubMedCrossRefGoogle Scholar
  17. 17.
    Bellorin-Font E, Martin KJ (1981) Regulation of the PTH-receptor-cyclase system of canine kidney: effects of calcium, magnesium and guanine nucleotides. Am J Physiol 241:F364-F373PubMedGoogle Scholar
  18. 18.
    Rodan SB, Golub EE, Egan JJ, Rodan GA (1980) Comparison of bone and osteosarcoma adenylate cyclase. Biochem J 185:629–637PubMedGoogle Scholar
  19. 19.
    Sonnenberg J, Pansini AR, Christakos S (1984) Vitamin D-dependent rat renal calcium-binding protein: development of a radioimmunoassay, tissue distribution, and immunologic identificationGoogle Scholar
  20. 20.
    Woodard JC, Wevster PD, Carr AA (1972) Primary hypocalcemia, diarrhea and insensitivity to parathyroid hormone. Digest Dis 17:612–618CrossRefGoogle Scholar
  21. 21.
    Raisz LG, Niemann I (1969) Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture. Endocrinology 85:446–452PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • Robert K. Rude
    • 1
    • 2
  1. 1.Department of MedicineUniversity of Southern California School of MedicineLos Angeles
  2. 2.Bone and Connective Tissue Research LaboratoriesOrthopaedic Hospital/University of Southern CaliforniaLos Angeles

Personalised recommendations